Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for patients living with acute hepatic ...

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...

Hepatic fibrosis is a reversible wound healing response characterized by accumulation of extracellular matrix (ECM), or "scar," that follows chronic but not self-limited liver disease. The ECM ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic platelet accumulation ...

But a study published this year suggests up to 13 percent of people diagnosed with dementia in the US may have a misdiagnosis ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

Introduction: Hepatic artery pseudoaneurysm (HAP) is a rare and potentially life-threatening condition associated with high mortality. This study aims to review the etiology, clinical manifestations, ...

The aim of this study was to investigate the expression and function of BMP6 in chronic liver disease. Design BMP6 was analysed in hepatic samples from murine models of chronic liver injury and ...